The Burden of Inflammatory Bowel Disease (IBD)

Event Image

The Burden of Inflammatory Bowel Disease (IBD)



Dial-in Instructions:
The registration confirmation email will contain links to participate virtually. All registrants will receive communications from info@mbgh.org prior to the event.
When:  Sep 1, 2026 from 01:00 PM to 02:30 PM (CT)

View Agenda 

 

Event Description

The Burden of Inflammatory Bowel Disease (IBD): How Crohn’s Disease & Ulcerative Colitis Impact Workforce Health, Productivity and Total Cost of Care

For most employers, IBD may not be a top prevalence condition, but it can be a high-burden condition that leads to high-cost claims if not appropriately managed. It can have significant implications for employers related to cost and productivity, but it is clinically manageable when benefits are aligned with evidence-based care. This webinar will outline the IBD landscape, explaining the barriers to timely diagnosis and appropriate treatment, along with evidence-informed strategies to improve outcomes. Additionally, employer insights and experiences will be shared to highlight the key challenges and solutions for optimizing care delivery and benefit design.

Learning Objectives:

  • Understand the current inflammatory bowel disease (IBD) landscape and the key barriers to timely diagnosis, evidence-informed treatment, and sustained disease control
  • Learn the role employers hold in improving IBD outcomes through benefit design, vendor accountability, and strategies that promote timely access to appropriate therapies
  • Understand how evidence-informed approaches enhance workforce health and reduce total cost of care for employers and for employees living with IBD


This program is only available virtually.

Registration Fees

  • MBGH Members $0
  • Employer Non-Members $50
  • Other Non-Members $150

Register

  

More information